Literature DB >> 31852798

Elite control of HIV is associated with distinct functional and transcriptional signatures in lymphoid tissue CD8+ T cells.

Son Nguyen1, Claire Deleage2, Samuel Darko3, Amy Ransier3, Duc P Truong4, Divyansh Agarwal5, Alberto Sada Japp1, Vincent H Wu1, Leticia Kuri-Cervantes1, Mohamed Abdel-Mohsen6, Perla M Del Rio Estrada7, Yuria Ablanedo-Terrazas7, Emma Gostick8, James A Hoxie9, Nancy R Zhang5, Ali Naji10, Gustavo Reyes-Terán7, Jacob D Estes11,12, David A Price8, Daniel C Douek3, Steven G Deeks13, Marcus Buggert14, Michael R Betts15.   

Abstract

The functional properties of circulating CD8+ T cells have been associated with immune control of HIV. However, viral replication occurs predominantly in secondary lymphoid tissues, such as lymph nodes (LNs). We used an integrated single-cell approach to characterize effective HIV-specific CD8+ T cell responses in the LNs of elite controllers (ECs), defined as individuals who suppress viral replication in the absence of antiretroviral therapy (ART). Higher frequencies of total memory and follicle-homing HIV-specific CD8+ T cells were detected in the LNs of ECs compared with the LNs of chronic progressors (CPs) who were not receiving ART. Moreover, HIV-specific CD8+ T cells potently suppressed viral replication without demonstrable cytolytic activity in the LNs of ECs, which harbored substantially lower amounts of CD4+ T cell-associated HIV DNA and RNA compared with the LNs of CPs. Single-cell RNA sequencing analyses further revealed a distinct transcriptional signature among HIV-specific CD8+ T cells from the LNs of ECs, typified by the down-regulation of inhibitory receptors and cytolytic molecules and the up-regulation of multiple cytokines, predicted secreted factors, and components of the protein translation machinery. Collectively, these results provide a mechanistic framework to expedite the identification of novel antiviral factors, highlighting a potential role for the localized deployment of noncytolytic functions as a determinant of immune efficacy against HIV.
Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Year:  2019        PMID: 31852798      PMCID: PMC7265335          DOI: 10.1126/scitranslmed.aax4077

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  67 in total

1.  CTL fail to accumulate at sites of HIV-1 replication in lymphoid tissue.

Authors:  Elizabeth Connick; Teresa Mattila; Joy M Folkvord; Rick Schlichtemeier; Amie L Meditz; M Graham Ray; Martin D McCarter; Samantha Mawhinney; Aaron Hage; Cara White; Pamela J Skinner
Journal:  J Immunol       Date:  2007-06-01       Impact factor: 5.422

Review 2.  Perforin and granzymes: function, dysfunction and human pathology.

Authors:  Ilia Voskoboinik; James C Whisstock; Joseph A Trapani
Journal:  Nat Rev Immunol       Date:  2015-06       Impact factor: 53.106

3.  HIV-specific CD8+ T-cell proliferation is prospectively associated with delayed disease progression.

Authors:  Lyle R McKinnon; Rupert Kaul; Joshua Kimani; Nico J Nagelkerke; Charles Wachihi; Keith R Fowke; Terry Blake Ball; Francis A Plummer
Journal:  Immunol Cell Biol       Date:  2011-05-24       Impact factor: 5.126

4.  Associations of Simian Immunodeficiency Virus (SIV)-Specific Follicular CD8+ T Cells with Other Follicular T Cells Suggest Complex Contributions to SIV Viremia Control.

Authors:  Mohammad Arif Rahman; Katherine M McKinnon; Tatiana S Karpova; David A Ball; David J Venzon; Wenjin Fan; Guobin Kang; Qingsheng Li; Marjorie Robert-Guroff
Journal:  J Immunol       Date:  2018-03-05       Impact factor: 5.422

5.  HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors.

Authors:  S A Migueles; M S Sabbaghian; W L Shupert; M P Bettinotti; F M Marincola; L Martino; C W Hallahan; S M Selig; D Schwartz; J Sullivan; M Connors
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

Review 6.  Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy.

Authors:  Steven G Deeks; Bruce D Walker
Journal:  Immunity       Date:  2007-09       Impact factor: 31.745

Review 7.  Role of lymphoid organs in the pathogenesis of human immunodeficiency virus (HIV) infection.

Authors:  G Pantaleo; C Graziosi; J F Demarest; O J Cohen; M Vaccarezza; K Gantt; C Muro-Cacho; A S Fauci
Journal:  Immunol Rev       Date:  1994-08       Impact factor: 12.988

8.  PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes.

Authors:  Vamsi K Mootha; Cecilia M Lindgren; Karl-Fredrik Eriksson; Aravind Subramanian; Smita Sihag; Joseph Lehar; Pere Puigserver; Emma Carlsson; Martin Ridderstråle; Esa Laurila; Nicholas Houstis; Mark J Daly; Nick Patterson; Jill P Mesirov; Todd R Golub; Pablo Tamayo; Bruce Spiegelman; Eric S Lander; Joel N Hirschhorn; David Altshuler; Leif C Groop
Journal:  Nat Genet       Date:  2003-07       Impact factor: 38.330

9.  HIV-Specific CD8+ T Cells Exhibit Reduced and Differentially Regulated Cytolytic Activity in Lymphoid Tissue.

Authors:  Morgan A Reuter; Perla M Del Rio Estrada; Marcus Buggert; Constantinos Petrovas; Sara Ferrando-Martinez; Son Nguyen; Alberto Sada Japp; Yuria Ablanedo-Terrazas; Amaranta Rivero-Arrieta; Leticia Kuri-Cervantes; Heidi M Gunzelman; Emma Gostick; David A Price; Richard A Koup; Ali Naji; David H Canaday; Gustavo Reyes-Terán; Michael R Betts
Journal:  Cell Rep       Date:  2017-12-19       Impact factor: 9.423

10.  ROTS: An R package for reproducibility-optimized statistical testing.

Authors:  Tomi Suomi; Fatemeh Seyednasrollah; Maria K Jaakkola; Thomas Faux; Laura L Elo
Journal:  PLoS Comput Biol       Date:  2017-05-25       Impact factor: 4.475

View more
  32 in total

Review 1.  The CD8+ T Cell Noncytotoxic Antiviral Responses.

Authors:  Maelig G Morvan; Fernando C Teque; Christopher P Locher; Jay A Levy
Journal:  Microbiol Mol Biol Rev       Date:  2021-05-12       Impact factor: 11.056

2.  Functional impairment of HIV-specific CD8+ T cells precedes aborted spontaneous control of viremia.

Authors:  David R Collins; Jonathan M Urbach; Zachary J Racenet; Umar Arshad; Karen A Power; Ruchi M Newman; Geetha H Mylvaganam; Ngoc L Ly; Xiaodong Lian; Anna Rull; Yelizaveta Rassadkina; Adrienne G Yanez; Michael J Peluso; Steven G Deeks; Francesc Vidal; Mathias Lichterfeld; Xu G Yu; Gaurav D Gaiha; Todd M Allen; Bruce D Walker
Journal:  Immunity       Date:  2021-09-07       Impact factor: 43.474

3.  Spontaneous Control of SIV Replication Does Not Prevent T Cell Dysregulation and Bacterial Dissemination in Animals Co-Infected with M. tuberculosis.

Authors:  Ryan V Moriarty; Mark A Rodgers; Amy L Ellis; Alexis J Balgeman; Erica C Larson; Forrest Hopkins; Michael R Chase; Pauline Maiello; Sarah M Fortune; Charles A Scanga; Shelby L O'Connor
Journal:  Microbiol Spectr       Date:  2022-04-25

4.  A cellular trafficking signal in the SIV envelope protein cytoplasmic domain is strongly selected for in pathogenic infection.

Authors:  Scott P Lawrence; Samra E Elser; Workineh Torben; Robert V Blair; Bapi Pahar; Pyone P Aye; Faith Schiro; Dawn Szeltner; Lara A Doyle-Meyers; Beth S Haggarty; Andrea P O Jordan; Josephine Romano; George J Leslie; Xavier Alvarez; David H O'Connor; Roger W Wiseman; Christine M Fennessey; Yuan Li; Michael Piatak; Jeffrey D Lifson; Celia C LaBranche; Andrew A Lackner; Brandon F Keele; Nicholas J Maness; Mark Marsh; James A Hoxie
Journal:  PLoS Pathog       Date:  2022-06-17       Impact factor: 7.464

5.  Transcriptomic Analysis Reveals Receptor Subclass-Specific Immune Regulation of CD8+ T Cells by Opioids.

Authors:  Claire Mazahery; Saba Valadkhan; Alan D Levine
Journal:  Immunohorizons       Date:  2020-07-16

6.  Epigenetic scars of CD8+ T cell exhaustion persist after cure of chronic infection in humans.

Authors:  W Nicholas Haining; Debattama R Sen; Kathleen B Yates; Pierre Tonnerre; Genevieve E Martin; Ulrike Gerdemann; Rose Al Abosy; Dawn E Comstock; Sarah A Weiss; David Wolski; Damien C Tully; Raymond T Chung; Todd M Allen; Arthur Y Kim; Sarah Fidler; Julie Fox; John Frater; Georg M Lauer
Journal:  Nat Immunol       Date:  2021-07-26       Impact factor: 25.606

7.  The Identity of Human Tissue-Emigrant CD8+ T Cells.

Authors:  Marcus Buggert; Laura A Vella; Son Nguyen; Vincent H Wu; Zeyu Chen; Takuya Sekine; André Perez-Potti; Colby R Maldini; Sasikanth Manne; Samuel Darko; Amy Ransier; Leticia Kuri-Cervantes; Alberto Sada Japp; Irene Bukh Brody; Martin A Ivarsson; Jean-Baptiste Gorin; Olga Rivera-Ballesteros; Laura Hertwig; Jack P Antel; Matthew E Johnson; Afam Okoye; Louis Picker; Golnaz Vahedi; Ernesto Sparrelid; Sian Llewellyn-Lacey; Emma Gostick; Johan K Sandberg; Niklas Björkström; Amit Bar-Or; Yoav Dori; Ali Naji; David H Canaday; Terri M Laufer; Andrew D Wells; David A Price; Ian Frank; Daniel C Douek; E John Wherry; Maxim G Itkin; Michael R Betts
Journal:  Cell       Date:  2020-12-10       Impact factor: 66.850

8.  In Situ Characterization of Human Lymphoid Tissue Immune Cells by Multispectral Confocal Imaging and Quantitative Image Analysis; Implications for HIV Reservoir Characterization.

Authors:  Eirini Moysi; Perla M Del Rio Estrada; Fernanda Torres-Ruiz; Gustavo Reyes-Terán; Richard A Koup; Constantinos Petrovas
Journal:  Front Immunol       Date:  2021-06-09       Impact factor: 7.561

Review 9.  Immunological effector mechanisms in HIV-1 elite controllers.

Authors:  Ciputra Adijaya Hartana; Xu G Yu
Journal:  Curr Opin HIV AIDS       Date:  2021-09-01       Impact factor: 4.061

Review 10.  How elite controllers and posttreatment controllers inform our search for an HIV-1 cure.

Authors:  Jonathan Z Li; Joel N Blankson
Journal:  J Clin Invest       Date:  2021-06-01       Impact factor: 19.456

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.